Jeffrey G. Spragens - 28 Feb 2023 Form 4 Insider Report for SAB Biotherapeutics, Inc. (SABS)

Role
Director
Signature
/s/ Jeffrey G. Spragens
Issuer symbol
SABS
Transactions as of
28 Feb 2023
Net transactions value
$0
Form type
4
Filing time
02 Mar 2023, 08:20:24 UTC
Previous filing
09 Dec 2022
Next filing
17 Jul 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SABS Warrants Other $0 +19,936 $0.000000 19,936 28 Feb 2023 Common Stock 19,936 $11.50 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Pro rata distribution by Big Cypress Holdings LLC to its members for which no consideration is being paid in connection with such distribution. The Reporting Person is a member of Big Cypress Holdings LLC, and as part of the distribution received 19,936 warrants of the issuer.